[go: up one dir, main page]

NO20000016D0 - Sykliske azapeptider med angiogen virkning - Google Patents

Sykliske azapeptider med angiogen virkning

Info

Publication number
NO20000016D0
NO20000016D0 NO20000016A NO20000016A NO20000016D0 NO 20000016 D0 NO20000016 D0 NO 20000016D0 NO 20000016 A NO20000016 A NO 20000016A NO 20000016 A NO20000016 A NO 20000016A NO 20000016 D0 NO20000016 D0 NO 20000016D0
Authority
NO
Norway
Prior art keywords
angiogenic activity
azapeptides
cyclic
cyclic azapeptides
angiogenic
Prior art date
Application number
NO20000016A
Other languages
English (en)
Other versions
NO20000016L (no
Inventor
Alfred Jonczyk
Simon Goodman
Horst Kessler
Jochen Wermuth
Joerg Schmitt
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20000016D0 publication Critical patent/NO20000016D0/no
Publication of NO20000016L publication Critical patent/NO20000016L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20000016A 1997-07-04 2000-01-03 Sykliske azapeptider med angiogen virkning NO20000016L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19728524A DE19728524A1 (de) 1997-07-04 1997-07-04 Cyclische Azapeptide
PCT/EP1998/003955 WO1999001472A1 (de) 1997-07-04 1998-06-29 Cyclische azapeptide mit angiogener wirkung

Publications (2)

Publication Number Publication Date
NO20000016D0 true NO20000016D0 (no) 2000-01-03
NO20000016L NO20000016L (no) 2000-01-03

Family

ID=7834596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000016A NO20000016L (no) 1997-07-04 2000-01-03 Sykliske azapeptider med angiogen virkning

Country Status (20)

Country Link
US (1) US6534478B1 (no)
EP (1) EP1001979B1 (no)
JP (1) JP2002511872A (no)
KR (1) KR20010014267A (no)
CN (1) CN1261895A (no)
AR (1) AR010924A1 (no)
AT (1) ATE297947T1 (no)
AU (1) AU733831B2 (no)
BR (1) BR9810394A (no)
CA (1) CA2297181A1 (no)
DE (2) DE19728524A1 (no)
HU (1) HUP0003357A3 (no)
ID (1) ID23415A (no)
NO (1) NO20000016L (no)
PL (1) PL337616A1 (no)
RU (1) RU2188205C2 (no)
SK (1) SK173599A3 (no)
TW (1) TW482768B (no)
WO (1) WO1999001472A1 (no)
ZA (1) ZA985896B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA71608C2 (en) * 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
WO2000078747A1 (en) * 1999-06-22 2000-12-28 Takeda Chemical Industries, Ltd. Acylhydrazine derivatives, process for preparing the same and use thereof
GB0217017D0 (en) * 2002-07-23 2002-08-28 Bioacta Ltd Peptide 2
WO2008033557A2 (en) * 2006-09-15 2008-03-20 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclic peptidomimetics as integrin markers
EP2182974B1 (en) * 2007-07-27 2015-08-26 Siemens Medical Solutions USA, Inc. Cyclic azapeptides as integrin markers
WO2009134382A2 (en) * 2008-04-30 2009-11-05 Siemens Medical Solutions Usa, Inc. Cyclopeptides containing rgd mimetics as imaging markers for integrins
WO2009148554A1 (en) * 2008-05-30 2009-12-10 Siemens Medical Solutions Usa, Inc. Achievement of high therapeutic index through molecular imaging guided targeted drug treatment
CA2665302A1 (en) * 2009-05-01 2010-11-01 Universite De Montreal Cd36 modulation and uses thereof
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
KR101335203B1 (ko) * 2010-03-26 2013-11-29 숙명여자대학교산학협력단 혈관신생촉진용 펩타이드 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98506A (en) * 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Cyclic peptide antibiotics processes for the preparation thereof and pharmaceutical compositions containing them
AU672010B2 (en) 1992-06-04 1996-09-19 Aventis Inc. Conformationally restrained peptide analogs as antiplatelet agents
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
WO1995023811A1 (en) 1994-03-04 1995-09-08 The Du Pont Merck Pharmaceutical Company Novel carbocyclic compounds which inhibit platelet aggregation by interaction with the gpiib/iiia receptor complex
US5858972A (en) 1996-01-11 1999-01-12 La Jolla Cancer Research Foundation Antithrombotic agents and methods of use
ZA978758B (en) * 1996-10-02 1999-03-30 Du Pont Merck Pharma Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents
DE19653036A1 (de) 1996-12-19 1998-06-25 Merck Patent Gmbh Cyclopeptidderivate

Also Published As

Publication number Publication date
BR9810394A (pt) 2000-09-05
ATE297947T1 (de) 2005-07-15
AU733831B2 (en) 2001-05-24
CA2297181A1 (en) 1999-01-14
EP1001979A1 (de) 2000-05-24
HUP0003357A2 (hu) 2001-02-28
DE19728524A1 (de) 1999-01-07
NO20000016L (no) 2000-01-03
AR010924A1 (es) 2000-07-12
EP1001979B1 (de) 2005-06-15
SK173599A3 (en) 2000-06-12
HUP0003357A3 (en) 2001-12-28
ZA985896B (en) 1999-06-14
AU8541198A (en) 1999-01-25
DE59812870D1 (de) 2005-07-21
RU2188205C2 (ru) 2002-08-27
PL337616A1 (en) 2000-08-28
ID23415A (id) 2000-04-20
US6534478B1 (en) 2003-03-18
JP2002511872A (ja) 2002-04-16
CN1261895A (zh) 2000-08-02
KR20010014267A (ko) 2001-02-26
TW482768B (en) 2002-04-11
WO1999001472A1 (de) 1999-01-14

Similar Documents

Publication Publication Date Title
DE69834050D1 (de) Elastisches befestigungsmittel
DE69829477D1 (de) Selbstnietendes befestigungselement
DE59802058D1 (de) Befestigungselement
FI970468A0 (fi) Anvaendningspraoksberoende bokstavsmatning med nummertangenter
DE59812562D1 (de) Kanülenanordnung
DE69835247D1 (de) Verbesserte Sensoranordnungen
FI974269A0 (fi) Radiosaendare-mottagarestruktur med tvao frekvensomraoden
DE69704706D1 (de) Mechanisches Befestigungselement
ID24203A (id) Pestisidal 1-aril-3-iminopirazol
IT1291353B1 (it) Peptidi con attivita&#39; antivirale
NO992103D0 (no) Dihydropyroner med forbedret antiviral aktivitet
NO20000016D0 (no) Sykliske azapeptider med angiogen virkning
DE69801856D1 (de) Befestigungselement
FI972664A0 (fi) Foerseglad saeck med avluftning
IT1304161B1 (it) Stiratoio
ID20897A (id) Susunan penutup-rapat
DE19881594D2 (de) Reisekinderbett
FI974544A0 (fi) Anordning i en med manoeverplats foersedd lastkran
KR970059635U (ko) 장구줄 조임구
NO980711D0 (no) Komponent i hudpleiemiddel
DE69816433D1 (de) Schiene
FI970405A0 (fi) Plattformad traeprodukt med skiktstruktur
KR970058978U (ko) 체결구
KR980000116U (ko) 발광등 부자
FI970017A0 (fi) Med lampeffekts maetning foersett reglerbart elektroniskt anslutningsorgan

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application